NCT00187889View on ClinicalTrials.gov

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

February 28, 2009

Study Completion Date

December 31, 2011

Conditions
Ischemic Heart Disease
Interventions
DRUG

Eplerenone

Eplerenone 25 mg (1 pill) daily for 1 week then uptitrated to 50 mg (2 pills) daily for 15 weeks.

DRUG

Placebo or sugar pill

Placebo blinded as 25 mg tablet(1 pill) once daily for 1 week then uptitrated to 50 mg (2 pills) daily for 15 weeks.

Trial Locations (1)

32610

University of Florida, Gainesville

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Pfizer

INDUSTRY

lead

University of Florida

OTHER